Cefuroxime

Breastfeeding
  • TRADE NAMES: Ceftin (GSK); Cefuril; Cepazine; Elobact; Froxal; Zinacef (Concordia); Zinacet; Zinat; Zinnat; Zoref
  • INDICATIONS: Various infections caused by susceptible organisms
  • CLASS: Cephalosporin, 2nd generation
  • HALF-LIFE: 1–2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

None known

PREGNANCY CATEGORY: B

Penicillin and cephalosporins share a common beta-lactam structure. People who are allergic to penicillin are approximately 4 times more likely to develop an allergic reaction to a cephalosporin than those people who have no penicillin allergy (from 5–16% of patients allergic to penicillin develop reactions to cephalosporins).

Our database has 50 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
LOCAL
OCULAR
OTIC
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric